Table 2 Histological predictors of local recurrence following breast-conserving surgery alone for DCIS: multivariable analysis (adjusted for age at diagnosis)

From: HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

Outcome

HR (95% CI)

P -value

Any local recurrence

  

 High nuclear grade

2.21 (1.14, 4.29)

0.02

 Multifocality

2.09 (1.09, 4.01)

0.03

 Tumour size

1.01 (0.94, 1.07)

0.89

 Margin size

0.96 (0.86, 1.06)

0.40

 Architectural subtype (solid vs other)

0.92 (0.45, 1.86)

0.82

DCIS recurrence

  

 High nuclear grade

4.09 (1.49, 11.23)

0.01

 Multifocality

2.66 (1.03, 6.88)

0.04

 Tumour size

1.04 (0.95, 1.13)

0.42

 Margin size

1.01 (0.87, 1.16)

0.95

 Architectural subtype (solid vs other)

1.35 (0.45, 4.03)

0.59

Invasive recurrence

  

 High nuclear grade

1.27 (0.49, 3.32)

0.62

 Multifocality

1.66 (0.66, 4.17)

0.28

 Tumour size

0.97 (0.88, 1.07)

0.54

 Margin size

0.92 (0.79, 1.07)

0.28

 Architectural subtype (solid vs other)

0.66 (0.26, 1.72)

0.40